Thats why these medications should only be used under the guidance of a licensed clinician who reviews your history, medications, and lab work
Lisa DiFrancesco is a female board-certified plastic surgeon based in Atlanta, GA
EndoSlim Clinic NY of Atlantic Gastroenterology in Brooklyn, New York, understands the visible and invisible burden shouldered by patients battling obesity
ACT 2: What Insurance Coverage Will Actually Look Like The second layer of the access problem is insurance, and the precedent is genuinely discouraging
New England Journal of Medicine: Retatrutide Phase 2 trial results - The landmark study establishing retatrutide efficacy and safety across multiple dose groups New England Journal of Medicine: STEP 1 semaglutide trial results - The pivotal trial demonstrating semaglutide 2.4 mg weight loss efficacy ClinicalTrials.gov: Retatrutide TRIUMPH program - Current status and details of all ongoing Phase 3 retatrutide trials FDA prescribing information for Wegovy (semaglutide 2.4 mg) - Complete approved labeling including dosing, safety, and clinical data New England Journal of Medicine: SELECT cardiovascular outcomes trial - The trial demonstrating semaglutide 20% reduction in major cardiovascular events These primary sources should be the foundation for any serious evaluation of either compound

Additionally, certain early signals including a possible association between GLP-1 use and elevated kidney cancer risk, as well as questions regarding long-term thyroid safety underscore the importance of individualised clinical assessment and ongoing medical supervision